Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Conference on Instrumentations and Biotechnologies 2012

12 Nov 2012 - 14 Nov 2012 - Shanghai Everbright International Hotel



Bookmark and Share


Mission

CIB promotes scientific communication between academics and companies with interests in biotechnologies and instrumentations.

CIB Objectives

Create a platform and an opportunity for scientists, clinicians and researchers to communicate about topics in advanced biotechnologies and instrumentations for application to clinical research.
Act as a bridge between academics and companies to understand the development of advanced biotechnologies instrumentations, and their potential for commercialization and clinical application.
Strengthen and enhance academic dialogue and information exchange between biotechnology companies, industries and manufacturers, thereby facilitating the development of collaborative projects or partnerships.

Discuss the use of new instrumentations and devices in clinical practice and feed back experience of the instrumentations and devices to the manufacturers

Focuses

1.    Cyto-pharmacology, metabolism, efficacy and survival
2.    The use of clinical proteomic technologies, tissue imaging proteomics, antibody microarray and biomarkers for diagnosis, therapy and prognosis of disease
3.    Clinical gene microarray technologies in diagnosis of disease
4.    Cellular mathematics, biophysics, bioinformatics and computational biology
5.    Functional and molecular imaging, cellular imaging, tissue imaging and in vivo imaging
6.    Flow cytometry, cellomics, metabomics, and stem cell biology
7.    Organ functional measurements
8.    Laser capture microdissection, molecular pathologies, tissue microarray, digital imaging analysis and morphometric systems
9.    Experimental magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), thermography, and ultrasound imaging technologies
10.   Tissue bioengineering technologies

Audience and participants

Scientists, clinicians, researchers and students from universities, institutes, hospitals, and companies working on medical biotechnologies and instrumentations.



Further information
Scientific News
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!